Tuesday, March 15th, 2011
DOSIsoft, SA. the spin-off from Gustave Roussy institute and Curie Institute, today announced that 510(k) clearance was granted by the U.S. Food and Drug Administration (FDA) to market the ISOgray Treatment Planning Sytem (TPS), indicated for use in external beam radiotherapy to generate beam shapes and 3D dose distribution with the intent to maximize the required dose to the target volume while minimizing dose to surrounding normal tissue and organs at risk (OAR) complications for the patient.
Dosisoft
45/47, avenue Carnot
94230 Cachan - France
Tel: +33 (0)1 41 24 26 26
Fax: +33 (0)1 41 24 26 28